Evaluating Your Current Options in the Treatment of NSCLC with METex14 Skipping Mutations

 
Condividi
 

Manage episode 344234080 series 3381434
Creato da ReachMD, autore scoperto da Player FM e dalla nostra community - Il copyright è detenuto dall'editore, non da Player FM, e l'audio viene riprodotto direttamente dal suo server. Clicca sul pulsante Iscriviti per rimanere aggiornato su Player FM, o incolla l'URL del feed in un altra app per i podcast.
CME credits: 0.25
Valid until: 02-11-2023
Claim your CME credit at https://reachmd.com/programs/cme/evaluating-your-current-options-in-the-treatment-of-nsclc-with-metex14-skipping-mutations/14089/
Take a deep dive into current and ongoing clinical trials related to MET inhibitors and discover the key distinctions between these agents, such as dosing differences. Our experts also have recommendations on appropriate therapy selection for your patients with advanced NSCLC harboring MET exon 14 skipping mutations.

764 episodi